New Clinical Trials for Pancreatic Cancer
If you have been diagnosed with pancreatic cancer, odds are that you have needed to make quite a few difficult decisions since your oncologist first told you about your disease. No matter what type of cancer you have, one of the most important decisions that need to be made is choosing which course of treatment you want to go with.
Some people may not realize that their are new clinical trials for cancer. Hopefully, someone from your healthcare team has informed you of the pancreatic clinical trials which you can take part in.
If you or a loved one have been diagnosed with pancreatic cancer, then we encourage you to peruse our list of new and ongoing pancreatic clinical studies. We realize that the thought of participating in a clinical trial may make some uneasy, but your participation helps health care experts gain a better understanding of this deadly disease. Following their diagnosis, many pancreatic cancer patients are faced with a rather grim prognosis, but a clinical trial could provide the answer that conventional cancer treatment cannot.
What is Pancreatic Cancer?
The pancreas is a gland that plays a vital role in the digestive and endocrine systems of human beings. This type of cancer originates in the tissues of this vital organ as cells that display signs of uncontrolled growth, metastasis, and/or invasion. The cells undergo what is known as an anomalous transformation that causes them to form a structure known as a neoplasm. When a neoplasm begins to spread to other parts of the body, and/or destroys some nearby tissues, pancreatic cancer is formed.
Most people who are diagnosed with pancreatic cancer are given a rather poor prognosis. This type of cancer is notorious for its aggression, and the fact that it is rarely diagnosed at an early stage. Most cases tend to be asymptomatic until the disease has already metastasized to other parts of the body. Pancreatic cancer ranks as one of the most deadly cancers in the United States.
Pancreatic Cancer Treatments
A tumor that forms in the pancreas can spread rapidly to the surrounding areas, which will make surgery much more difficult. Also, most people who are diagnosed with pancreatic cancer are in their seventies and eighties, which further limits treatment options. Traditional cancer treatments like chemotherapy and radiation therapy could be too dangerous for their overall health. Given this overtly poor treatment prognosis, all pancreatic cancer patients should consider enrolling in a clinical trial.
We've found
774 Pancreatic Cancer
clinical trials
Pancreatic Cancer Clinical Trial
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 2/10/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Status: Enrolling,
Phase
I, II
Updated: 10/16/2010
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 1/16/2014
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Patients and Healthy Participants Undergoing Colonoscopy, Endoscopy, or Surgery
Status: Enrolling
Updated: 1/21/2013
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
RO4929097 in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 7/29/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase III FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine, Abraxane, Gemcitabine)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
Status: Enrolling,
Phase
I, II
Updated: 6/1/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Inovio TRT-001: Telomerase DNA Immunotherapy in Breast, Lung, and Pancreatic Cancers
Status: Enrolling,
Phase
I
Updated: 8/3/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Screening for PDAC in BRCA1/2 Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma
Status: Enrolling,
Phase
II
Updated: 3/28/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer
Status: Enrolling,
Phase
I
Updated: 5/21/2015
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects
Status: Enrolling,
Phase
I
Updated: 2/9/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Status: Enrolling,
Phase
I
Updated: 3/14/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Neoadjuvant/Adjuvant GVAX Pancreas Vaccine (With CY) With or Without Nivolumab and Urelumab Trial for Surgically Resectable Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Status: Enrolling,
Phase
Updated: 3/8/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study With CY, Pembrolizumab, GVAX, and SBRT in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
CAR T Cell Immunotherapy for Pancreatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Status: Enrolling,
Phase
I
Updated: 10/26/2017
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 4/20/2018
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*1101 Patients
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Updated: 2/10/2012
Updated: 10/16/2010
Updated: 1/16/2014
Updated: 1/16/2014
Updated: 1/16/2014
Updated: 1/16/2014
Updated: 1/16/2014
Updated: 1/16/2014
Updated: 1/16/2014
Updated: 1/21/2013
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 7/29/2012
Updated: 2/6/2018
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 6/1/2015
Updated: 8/3/2016
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 3/28/2016
Updated: 12/31/1969
Updated: 5/21/2015
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 2/9/2016
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 3/14/2018
Updated: 4/18/2018
Updated: 12/31/1969
Updated: 3/8/2016
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 4/23/2018
Updated: 4/23/2018
Updated: 4/23/2018
Updated: 4/23/2018
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 10/26/2017
Updated: 12/31/1969
Updated: 4/20/2018
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969